{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:09:32Z","timestamp":1793916572919,"version":"4.8.0"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12653-8","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:35:38Z","timestamp":1769686538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Global prevalence and trends of fluconazole resistance in non-albicans Candida species: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xuehua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sholeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahya Abedi","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Ostadrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Sedigheh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"9","key":"12653_CR1","doi-asserted-by":"publisher","first-page":"e0011464","DOI":"10.1371\/journal.pntd.0011464","volume":"17","author":"SA Ahmed","year":"2023","unstructured":"Ahmed SA, Ismail M, Albirair M, Nail AMA, Denning DW. Fungal infections in sudan: an underestimated health problem. PLoS Negl Trop Dis. 2023;17(9):e0011464.","journal-title":"PLoS Negl Trop Dis"},{"key":"12653_CR2","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.mam.2023.101215","volume":"94","author":"C Lass-Fl\u00f6rl","year":"2023","unstructured":"Lass-Fl\u00f6rl C, Steixner S. The changing epidemiology of fungal infections. Mol Aspects Med. 2023;94:101215.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"12653_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/jof4040121","volume":"4","author":"O Makanjuola","year":"2018","unstructured":"Makanjuola O, Bongomin F, Fayemiwo SA. An update on the roles of non-albicans Candida species in vulvovaginitis. J Fungi. 2018;4(4):121.","journal-title":"J Fungi"},{"issue":"2","key":"12653_CR4","first-page":"8","volume":"7","author":"DP Singh","year":"2021","unstructured":"Singh DP, Verma RK, Sarswat S, Saraswat S. Non-Candida albicans Candida species: virulence factors and species identification in India. Curr Med Mycol. 2021;7(2):8.","journal-title":"Curr Med Mycol"},{"key":"12653_CR5","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2017;7:2173.","journal-title":"Front Microbiol"},{"issue":"2","key":"12653_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","volume":"2","author":"D Sanglard","year":"2002","unstructured":"Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002;2(2):73\u201385.","journal-title":"Lancet Infect Dis"},{"key":"12653_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jgar.2017.12.011","volume":"13","author":"Z Yang","year":"2018","unstructured":"Yang Z, Wang Q, Ma K, Shi P, Liu W, Huang Z. Fluconazole inhibits cellular ergosterol synthesis to confer synergism with Berberine against yeast cells. J Global Antimicrob Resist. 2018;13:125\u201330.","journal-title":"J Global Antimicrob Resist"},{"issue":"6","key":"12653_CR8","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","volume":"121","author":"Y Lee","year":"2020","unstructured":"Lee Y, Puumala E, Robbins N, Cowen LE. Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev. 2020;121(6):3390\u2013411.","journal-title":"Chem Rev"},{"issue":"2","key":"12653_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jac\/dkz400","volume":"75","author":"AT Nishimoto","year":"2020","unstructured":"Nishimoto AT, Sharma C, Rogers PD. Molecular and genetic basis of Azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans. J Antimicrob Chemother. 2020;75(2):257\u201370.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"12653_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40475-021-00226-5","volume":"8","author":"F Bohner","year":"2021","unstructured":"Bohner F, Gacser A, Toth R. Epidemiological attributes of Candida species in tropical regions. Curr Trop Med Rep. 2021;8(2):59\u201368.","journal-title":"Curr Trop Med Rep"},{"key":"12653_CR11","doi-asserted-by":"crossref","unstructured":"Das K, Getso M, Azeez-Akande O. Distribution of Candida albicans and non-albicans Candida in clinical samples and their intrinsic biofilm production status. 2016.","DOI":"10.5455\/ijmsph.2016.26042016491"},{"issue":"3","key":"12653_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.5455\/ijmsph.2013.080320131","volume":"2","author":"S Deorukhkar","year":"2013","unstructured":"Deorukhkar S, Saini S. Non albicans Candida species: its isolation pattern, species distribution, virulence factors and antifungal susceptibility profile. Int J Med Sci Public Health. 2013;2(3):533\u20138.","journal-title":"Int J Med Sci Public Health"},{"key":"12653_CR13","unstructured":"Deorukhkar SC, Santosh Saini SS. Non albicans Candida species: a review of epidemiology, pathogenicity and antifungal resistance. 2015."},{"issue":"4","key":"12653_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/myc.13054","volume":"63","author":"DR Giacobbe","year":"2020","unstructured":"Giacobbe DR, Maraolo AE, Simeon V, Magn\u00e8 F, Pace MC, Gentile I, et al. Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in\u2010patients: a systematic review, meta\u2010analysis and meta\u2010regression. Mycoses. 2020;63(4):334\u201342.","journal-title":"Mycoses"},{"issue":"5","key":"12653_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/jof10050326","volume":"10","author":"JC Hern\u00e1ndez-Pab\u00f3n","year":"2024","unstructured":"Hern\u00e1ndez-Pab\u00f3n JC, Tabares B, Gil \u00d3, Lugo-S\u00e1nchez C, Santana A, Bar\u00f3n A, et al. Candida non-albicans and non-auris causing invasive candidiasis in a fourth-level hospital in colombia: epidemiology, antifungal susceptibility, and genetic diversity. J Fungi. 2024;10(5):326.","journal-title":"J Fungi"},{"issue":"6","key":"12653_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.archoralbio.2015.03.002","volume":"60","author":"T Muadcheingka","year":"2015","unstructured":"Muadcheingka T, Tantivitayakul P. Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: correlation between cell surface hydrophobicity and biofilm forming activities. Arch Oral Biol. 2015;60(6):894\u2013901.","journal-title":"Arch Oral Biol"},{"issue":"2","key":"12653_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","volume":"36","author":"S Silva","year":"2012","unstructured":"Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288\u2013305.","journal-title":"FEMS Microbiol Rev"},{"key":"12653_CR18","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1017\/S0950268819001638","volume":"147","author":"W Zhang","year":"2019","unstructured":"Zhang W, Song X, Wu H, Zheng R. Epidemiology, risk factors and outcomes of Candida albicans vs. non-albicans candidaemia in adult patients in Northeast China. Epidemiol Infect. 2019;147:e277.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"12653_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Fl\u00f6rl","year":"2024","unstructured":"Lass-Fl\u00f6rl C, Kanj SS, Govender NP, Thompson GR III, Ostrosky-Zeichner L, Govrins MA. Invasive candidiasis. Nat Reviews Disease Primers. 2024;10(1):20.","journal-title":"Nat Reviews Disease Primers"},{"issue":"6","key":"12653_CR20","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","volume":"4","author":"F Daneshnia","year":"2023","unstructured":"Daneshnia F, de Almeida J\u00fanior JN, Ilkit M, Lombardi L, Perry AM, Gao M, et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe. 2023;4(6):e470\u201380.","journal-title":"Lancet Microbe"},{"key":"12653_CR21","doi-asserted-by":"publisher","first-page":"1010782","DOI":"10.3389\/ffunb.2022.1010782","volume":"3","author":"P Escribano","year":"2022","unstructured":"Escribano P, Guinea J. Fluconazole-resistant Candida parapsilosis: a new emerging threat in the fungi arena. Front Fungal Biology. 2022;3:1010782.","journal-title":"Front Fungal Biology"},{"key":"12653_CR22","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. med PGJP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 2009;6(7):e1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"12653_CR23","unstructured":"CLSI. Performance Standards for Antifungal Susceptibility Testing of Yeasts. 3rd ed. CLSI supplement M27M44S. Clinical and Laboratory Standards Institute. 2022."},{"issue":"6","key":"12653_CR24","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/AAC.46.6.1781-1784.2002","volume":"46","author":"A Barry","year":"2002","unstructured":"Barry A, Pfaller M, Rennie R, Fuchs P, Brown S. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother. 2002;46(6):1781\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12653_CR25","first-page":"e0147601","volume":"11","author":"P Modesti","year":"2016","unstructured":"Modesti P, Reboldi G, Cappuccio FJPO. Newcastle-Ottawa quality assessment scale. (adapted Cross Sectional studies). 2016;11(1):e0147601.","journal-title":"(adapted Cross Sectional studies)"},{"key":"12653_CR26","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2. Wiley interdisciplinary reviews: computational statistics. 2011;3(2):180-5.","DOI":"10.1002\/wics.147"},{"key":"12653_CR27","doi-asserted-by":"publisher","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03.","DOI":"10.18637\/jss.v036.i03"},{"key":"12653_CR28","volume-title":"R: A Language and environment for statistical computing","author":"Team RCJhwR-po","year":"2013","unstructured":"Team RCJhwR-po. R: A Language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013."},{"key":"12653_CR29","doi-asserted-by":"crossref","unstructured":"Abad HSE, Zaini F, Kordbacheh P, Mahmoudi M, Safara M, Mortezaee V. In vitro activity of Caspofungin against fluconazole-resistant Candida species isolated from clinical samples in Iran. Jundishapur J Microbiol. 2015;8(6).","DOI":"10.5812\/jjm.18353v2"},{"key":"12653_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fcimb.2013.00074","volume":"3","author":"S Abbes","year":"2013","unstructured":"Abbes S, Mary C, Sellami H, Michel-Nguyen A, Ayadi A, Ranque S. Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata. Front Cell Infect Microbiol. 2013;3:74.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"12653_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/13693786.2010.493561","volume":"49","author":"S Abbes","year":"2011","unstructured":"Abbes S, Sellami H, Sellami A, Makni F, Mahfoudh N, Makni H, et al. Microsatellite analysis and susceptibility to FCZ of Candida glabrata invasive isolates in Sfax Hospital, Tunisia. Med Mycol. 2011;49(1):10\u20135.","journal-title":"Med Mycol"},{"issue":"10","key":"12653_CR32","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.31557\/APJCP.2023.24.10.3403","volume":"24","author":"DUR Aisy","year":"2023","unstructured":"Aisy DUR, Adawiyah R, Rozaliyani A, Estuningtyas A, Fadilah F. The antifungal activities of syzygium aromaticum and Alpinia purpurata extracts against Candida krusei: bioactivity tests, molecular modeling, and toxicity tests. Asian Pac J Cancer Prevention: APJCP. 2023;24(10):3403.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"key":"12653_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s15010-019-01275-9","volume":"47","author":"V Al Jalali","year":"2019","unstructured":"Al Jalali V, Sauermann R, Eberl S, Zeitlinger M. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid. Infection. 2019;47:565\u201370.","journal-title":"Infection"},{"key":"12653_CR34","doi-asserted-by":"publisher","first-page":"1434677","DOI":"10.3389\/fcimb.2024.1434677","volume":"14","author":"M Ali","year":"2024","unstructured":"Ali M, Edrees WH, Al-Shehari WA, Xue G, Al-Hammadi S, Qasem EA, et al. Antifungal susceptibility pattern of Candida species isolated from pregnant women. Front Cell Infect Microbiol. 2024;14:1434677.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"12653_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.29252\/cmm.3.1.13","volume":"3","author":"F Alizadeh","year":"2017","unstructured":"Alizadeh F, Khodavandi A, Zalakian S. Quantitation of ergosterol content and gene expression profile of ERG11 gene in fluconazole-resistant Candida albicans. Curr Med Mycol. 2017;3(1):13.","journal-title":"Curr Med Mycol"},{"key":"12653_CR36","doi-asserted-by":"publisher","first-page":"foae035","DOI":"10.1093\/femsyr\/foae035","volume":"24","author":"A Arastehfar","year":"2024","unstructured":"Arastehfar A, Daneshnia F, Hovhannisyan H, Cabrera N, Ilkit M, Desai JV, et al. A multidimensional assessment of in-host fitness costs of drug resistance in the opportunistic fungal pathogen Candida glabrata. FEMS Yeast Res. 2024;24:foae035.","journal-title":"FEMS Yeast Res"},{"key":"12653_CR37","doi-asserted-by":"publisher","first-page":"1242622","DOI":"10.3389\/fpubh.2023.1242622","volume":"11","author":"M Asadzadeh","year":"2023","unstructured":"Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of Candida glabrata in Kuwait. Front Public Health. 2023;11:1242622.","journal-title":"Front Public Health"},{"issue":"4","key":"12653_CR38","doi-asserted-by":"publisher","first-page":"e01474","DOI":"10.1128\/spectrum.01474-23","volume":"11","author":"M Asadzadeh","year":"2023","unstructured":"Asadzadeh M, Alfouzan W, Parker JE, Meis JF, Kelly SL, Joseph L, et al. Molecular characterization and sterol profiles identify nonsynonymous mutations in ERG2 as a major mechanism conferring reduced susceptibility to amphotericin B in Candida Kefyr. Microbiol Spectr. 2023;11(4):e01474\u201323.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"12653_CR39","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3390\/ijms24021449","volume":"24","author":"MJ Azevedo","year":"2023","unstructured":"Azevedo MJ, Araujo R, Campos J, Campos C, Ferreira AF, Falc\u00e3o-Pires I, et al. Vertical transmission and antifungal susceptibility profile of yeast isolates from the oral cavity, gut, and breastmilk of mother\u2013child pairs in early life. Int J Mol Sci. 2023;24(2):1449.","journal-title":"Int J Mol Sci"},{"issue":"01","key":"12653_CR40","doi-asserted-by":"publisher","first-page":"075","DOI":"10.3855\/jidc.1086","volume":"5","author":"P Badiee","year":"2011","unstructured":"Badiee P, Alborzi A, Farhoudi F. A case of Candida mediastinitis after dental extraction. J Infect Developing Ctries. 2011;5(01):075\u20138.","journal-title":"J Infect Developing Ctries"},{"issue":"9","key":"12653_CR41","doi-asserted-by":"publisher","first-page":"e24198","DOI":"10.1371\/journal.pone.0024198","volume":"6","author":"M Bassetti","year":"2011","unstructured":"Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE. 2011;6(9):e24198.","journal-title":"PLoS ONE"},{"issue":"5","key":"12653_CR42","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/AAC.05947-11","volume":"56","author":"R Ben-Ami","year":"2012","unstructured":"Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, et al. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012;56(5):2518\u201323.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"12653_CR43","first-page":"e01619","volume":"68","author":"S Bergin","year":"2024","unstructured":"Bergin S, Doorley LA, Rybak JM, Wolfe KH, Butler G, Cuomo CA, et al. Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes. Antimicrob Agents Chemother. 2024;68(6):e01619\u201323.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12653_CR44","doi-asserted-by":"publisher","first-page":"2302843","DOI":"10.1080\/22221751.2024.2302843","volume":"13","author":"J Bing","year":"2024","unstructured":"Bing J, Du H, Guo P, Hu T, Xiao M, Lu S, et al. Candida auris-associated hospitalizations and outbreaks, China, 2018\u20132023. Emerg Microbes Infections. 2024;13(1):2302843.","journal-title":"Emerg Microbes Infections"},{"issue":"7","key":"12653_CR45","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3201\/eid2907.221888","volume":"29","author":"R Biran","year":"2023","unstructured":"Biran R, Cohen R, Finn T, Brosh-Nissimov T, Rahav G, Yahav D, et al. Nationwide outbreak of Candida auris infections driven by COVID-19 hospitalizations, Israel, 2021\u20132022. Emerg Infect Dis. 2023;29(7):1302.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"12653_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1128\/JCM.01986-07","volume":"46","author":"JA Bishop","year":"2008","unstructured":"Bishop JA, Chase N, Magill SS, Kurtzman CP, Fiandaca MJ, Merz WG. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and Documentation of presumed infection. J Clin Microbiol. 2008;46(2):443\u20136.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"12653_CR47","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1099\/jmm.0.037812-0","volume":"61","author":"LX Bonfietti","year":"2012","unstructured":"Bonfietti LX, Martins MA, Szeszs MW, Pukiskas SBS, Purisco SU, Pimentel FC, et al. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates. J Med Microbiol. 2012;61(7):1003\u20138.","journal-title":"J Med Microbiol"},{"key":"12653_CR48","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10096-011-1242-x","volume":"30","author":"E Borghi","year":"2011","unstructured":"Borghi E, Sciota R, Iatta R, Biassoni C, Montagna M, Morace G. Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections. Eur J Clin Microbiol Infect Dis. 2011;30:1437\u201341.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"12653_CR49","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s10096-014-2069-z","volume":"33","author":"N Bourgeois","year":"2014","unstructured":"Bourgeois N, Laurens C, Bertout S, Balard Y, Krasteva D, Rispail P, et al. Assessment of Caspofungin susceptibility of Candida glabrata by the Etest\u00ae, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations. Eur J Clin Microbiol Infect Dis. 2014;33:1247\u201352.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"12653_CR50","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1099\/jmm.0.076216-0","volume":"63","author":"RSN Brilhante","year":"2014","unstructured":"Brilhante RSN, Rodrigues TJS, Castelo-Branco DSCM, Teixeira CEC, Macedo RB, Bandeira SP, et al. Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. J Med Microbiol. 2014;63(11):1568\u201372.","journal-title":"J Med Microbiol"},{"issue":"3","key":"12653_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jac\/dkl521","volume":"59","author":"I Bruzual","year":"2007","unstructured":"Bruzual I, Riggle P, Hadley S, Kumamoto CA. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. J Antimicrob Chemother. 2007;59(3):441\u201350.","journal-title":"J Antimicrob Chemother"},{"key":"12653_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ajo.2024.01.018","volume":"262","author":"E Burton","year":"2024","unstructured":"Burton E, Reddy V, Venkat AG. Endogenous fungal endophthalmitis: a single-center retrospective study and review of the literature. Am J Ophthalmol. 2024;262:97\u2013106.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"12653_CR53","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1099\/jmm.0.071167-0","volume":"63","author":"B Bustamante","year":"2014","unstructured":"Bustamante B, Martins M, Bonfietti L, Szeszs M, Jacobs J, Garcia C, et al. Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru. J Med Microbiol. 2014;63(6):855\u201360.","journal-title":"J Med Microbiol"},{"issue":"12","key":"12653_CR54","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1128\/AAC.00466-11","volume":"55","author":"E Cant\u00f3n","year":"2011","unstructured":"Cant\u00f3n E, Pem\u00e1n J, Quind\u00f3s G, Eraso E, Miranda-Zapico I, \u00c1lvarez M, et al. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother. 2011;55(12):5590\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"12653_CR55","doi-asserted-by":"publisher","first-page":"e00570","DOI":"10.1128\/aac.00570-24","volume":"68","author":"M Castanheira","year":"2024","unstructured":"Castanheira M, Deshpande LM, Rhomberg PR, Carvalhaes CG. Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization. Antimicrob Agents Chemother. 2024;68(10):e00570\u201324.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"12653_CR56","doi-asserted-by":"publisher","first-page":"e00564","DOI":"10.1128\/spectrum.00564-24","volume":"12","author":"FT \u00c7etin","year":"2024","unstructured":"\u00c7etin FT, \u00c7ay \u00dc, Polat M, K\u0131l\u0131n\u00e7 F, \u00dcnal A, Tapa\u00e7 NN, et al. Candida parapsilosis candidemia in children admitted to a tertiary hospital in turkey: clinical features and antifungal susceptibility. Microbiol Spectr. 2024;12(7):e00564\u201324.","journal-title":"Microbiol Spectr"},{"issue":"8","key":"12653_CR57","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/jac\/dkae200","volume":"79","author":"P-Y Chen","year":"2024","unstructured":"Chen P-Y, Huang Y-S, Chuang Y-C, Wang J-T, Sheng W-H, Chen Y-C, et al. Implication of genotypes for prognosis of Candida glabrata bloodstream infections. J Antimicrob Chemother. 2024;79(8):2008\u201316.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"12653_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.kjms.2011.11.011","volume":"28","author":"T-C Chen","year":"2012","unstructured":"Chen T-C, Chen Y-H, Chen Y-C, Lu P-L. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to Triazole antifungal agents. Kaohsiung J Med Sci. 2012;28(6):306\u201315.","journal-title":"Kaohsiung J Med Sci"},{"issue":"6","key":"12653_CR59","doi-asserted-by":"publisher","first-page":"e01471","DOI":"10.1128\/spectrum.01471-23","volume":"11","author":"Y-Z Chen","year":"2023","unstructured":"Chen Y-Z, Tseng K-Y, Wang S-C, Huang C-L, Lin C-C, Zhou Z-L, et al. Fruits are vehicles of drug-resistant pathogenic Candida tropicalis. Microbiol Spectr. 2023;11(6):e01471\u201323.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"12653_CR60","doi-asserted-by":"publisher","first-page":"03364","DOI":"10.1128\/mbio","volume":"11","author":"NA Chow","year":"2020","unstructured":"Chow NA, Mu\u00f1oz JF, Gade L, Berkow EL, Li X, Welsh RM, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. MBio. 2020;11(2):03364\u201319. https:\/\/doi.org\/10.1128\/mbio.","journal-title":"MBio"},{"issue":"10","key":"12653_CR61","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","volume":"55","author":"AA Cleveland","year":"2012","unstructured":"Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011. Clin Infect Dis. 2012;55(10):1352\u201361.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"12653_CR62","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/dkf060","volume":"49","author":"M Cuenca-Estrella","year":"2002","unstructured":"Cuenca-Estrella M, Rodero L, Garc\u00eda-Effr\u00f3n G, Rodriguez-Tudela JL. Antifungal susceptibilities of Candida spp. Isolated from blood in Spain and Argentina, 1996\u20131999. J Antimicrob Chemother. 2002;49(6):981\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"12653_CR63","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s42770-023-00943-1","volume":"54","author":"CM da Silva","year":"2023","unstructured":"da Silva CM, de Carvalho AMR, Mac\u00eado DPC, Juc\u00e1 MB, Amorim RJM, Neves RP. Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance. Brazilian J Microbiol. 2023;54(2):817\u201325.","journal-title":"Brazilian J Microbiol"},{"issue":"4","key":"12653_CR64","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1128\/AAC.00966-12","volume":"57","author":"CR da Silva","year":"2013","unstructured":"da Silva CR, de Andrade Neto JB, Sidrim JJC, \u00c2ngelo MRF, Magalh\u00e3es HIF, Cavalcanti BC, et al. Synergistic effects of Amiodarone and fluconazole on Candida tropicalis resistant to fluconazole. Antimicrob Agents Chemother. 2013;57(4):1691\u2013700.","journal-title":"Antimicrob Agents Chemother"},{"key":"12653_CR65","doi-asserted-by":"publisher","first-page":"1504866","DOI":"10.3389\/fcimb.2025.1504866","volume":"15","author":"Z Dai","year":"2025","unstructured":"Dai Z, Lan X, Cai M, Liao Y, Zhang J, Ye N, et al. Nineteen years retrospective analysis of epidemiology, antifungal resistance and a nomogram model for 30-day mortality in nosocomial candidemia patients. Front Cell Infect Microbiol. 2025;15:1504866.","journal-title":"Front Cell Infect Microbiol"},{"key":"12653_CR66","doi-asserted-by":"crossref","unstructured":"Daneshnia F, de Almeida J\u00fanior JN, Ilkit M, Lombardi L, Perry AM, Gao M, et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe. 2023.","DOI":"10.1016\/S2666-5247(23)00067-8"},{"issue":"3","key":"12653_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.riam.2014.06.003","volume":"32","author":"AA de Almeida","year":"2015","unstructured":"de Almeida AA, Nakamura SS, Fiorini A, Grisolia AB, Svidzinski TIE, de Oliveira KMP. Genotypic variability and antifungal susceptibility of Candida tropicalis isolated from patients with Candiduria. Revista Iberoamericana De micolog\u00eda. 2015;32(3):153\u20138.","journal-title":"Revista Iberoamericana De micolog\u00eda"},{"issue":"8","key":"12653_CR68","doi-asserted-by":"publisher","first-page":"e00710","DOI":"10.1128\/aac.00710-22","volume":"66","author":"J D\u00edaz-Garc\u00eda","year":"2022","unstructured":"D\u00edaz-Garc\u00eda J, G\u00f3mez A, Alcal\u00e1 L, Reigadas E, S\u00e1nchez-Carrillo C, P\u00e9rez-Ayala A, et al. Evidence of fluconazole-resistant Candida parapsilosis genotypes spreading across hospitals located in Madrid, Spain and harboring the Y132F ERG11p substitution. Antimicrob Agents Chemother. 2022;66(8):e00710\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"12653_CR69","doi-asserted-by":"publisher","first-page":"e255080","DOI":"10.1590\/1519-6984.255080","volume":"84","author":"H Diniz-Neto","year":"2022","unstructured":"Diniz-Neto H, Silva S, Cordeiro L, Silva D, Oliveira R, Athayde-Filho P, et al. Antifungal activity of 2-chloro-N-phenylacetamide: a new molecule with fungicidal and antibiofilm activity against fluconazole-resistant Candida spp. Brazilian J Biology. 2022;84:e255080.","journal-title":"Brazilian J Biology"},{"key":"12653_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1590\/S0074-02762012000100005","volume":"107","author":"M Dornelas-Ribeiro","year":"2012","unstructured":"Dornelas-Ribeiro M, Pinheiro EO, Guerra C, Braga-Silva LA, Carvalho SMFd S, ALSd, et al. Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth. Mem Inst Oswaldo Cruz. 2012;107:31\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"12653_CR71","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13756-022-01143-6","volume":"11","author":"CM Dunaiski","year":"2022","unstructured":"Dunaiski CM, Kock MM, Jung H, Peters RP. Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. Antimicrob Resist Infect Control. 2022;11(1):104.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7","key":"12653_CR72","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1128\/AAC.00555-13","volume":"57","author":"J Eddouzi","year":"2013","unstructured":"Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, et al. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrob Agents Chemother. 2013;57(7):3182\u201393.","journal-title":"Antimicrob Agents Chemother"},{"key":"12653_CR73","doi-asserted-by":"crossref","unstructured":"Eksi F, Gayyurhan ED, Balci I. In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method. Sci World J. 2013;2013.","DOI":"10.1155\/2013\/236903"},{"issue":"4","key":"12653_CR74","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/jac\/dks482","volume":"68","author":"GA Eschenauer","year":"2013","unstructured":"Eschenauer GA, Carver PL, Lin S-W, Klinker KP, Chen Y-C, Potoski BA, et al. Fluconazole versus an Echinocandin for Candida glabrata fungaemia: a retrospective cohort study. J Antimicrob Chemother. 2013;68(4):922\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"12653_CR75","doi-asserted-by":"publisher","first-page":"1125241","DOI":"10.3389\/fmicb.2023.1125241","volume":"14","author":"X Fan","year":"2023","unstructured":"Fan X, Tsui CK, Chen X, Wang P, Liu Z-j, Yang C-x. High prevalence of fluconazole resistant Candida tropicalis among Candiduria samples in china: an ignored matter of concern. Front Microbiol. 2023;14:1125241.","journal-title":"Front Microbiol"},{"key":"12653_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-21-1","volume":"21","author":"S Farahyar","year":"2013","unstructured":"Farahyar S, Zaini F, Kordbacheh P, Rezaie S, Safara M, Raoofian R, et al. Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP. DARU J Pharm Sci. 2013;21:1\u20137.","journal-title":"DARU J Pharm Sci"},{"issue":"11","key":"12653_CR77","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3201\/eid2011.140685","volume":"20","author":"D Farmakiotis","year":"2014","unstructured":"Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis. 2014;20(11):1833.","journal-title":"Emerg Infect Dis"},{"issue":"0 2","key":"12653_CR78","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1099\/jmm.0.048785-0","volume":"62","author":"J Farooqi","year":"2013","unstructured":"Farooqi J, Jabeen K, Saeed N, Iqbal N, Malik B, Lockhart S, et al. Invasive candidiasis in pakistan: clinical characteristics, species distribution and antifungal susceptibility. J Med Microbiol. 2013;62(0 2):259.","journal-title":"J Med Microbiol"},{"issue":"5","key":"12653_CR79","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.007","volume":"123","author":"L-j Feng","year":"2010","unstructured":"Feng L-j, Zhe W, Wang X-h, Li R-y, Wei L. Relationship between antifungal resistance of fluconazole ResistantCandida albicansand mutations inERG11 gene. Chin Med J. 2010;123(5):544\u20138.","journal-title":"Chin Med J"},{"issue":"12","key":"12653_CR80","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1093\/jac\/dkr394","volume":"66","author":"P Fournier","year":"2011","unstructured":"Fournier P, Schwebel C, Maubon D, Vesin A, Lebeau B, Foroni L, et al. Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. J Antimicrob Chemother. 2011;66(12):2880\u20136.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"12653_CR81","doi-asserted-by":"publisher","first-page":"e02265","DOI":"10.1128\/aac.02265-21","volume":"66","author":"F Fuchs","year":"2022","unstructured":"Fuchs F, Aldejohann AM, Hoffmann AM, Walther G, Kurzai O, Hamprecht AG. In vitro activity of nitroxoline in antifungal-resistant Candida species isolated from the urinary tract. Antimicrob Agents Chemother. 2022;66(6):e02265\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"12653_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1590\/S0037-86822011000500013","volume":"44","author":"MC Furlaneto","year":"2011","unstructured":"Furlaneto MC, Rota JF, Quesada RMB, Furlaneto-Maia L, Rodrigues R, Oda S, et al. Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period. Rev Soc Bras Med Trop. 2011;44:595\u20139.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3\u20134","key":"12653_CR83","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1159\/000453134","volume":"40","author":"M Gao","year":"2016","unstructured":"Gao M, Wang H, Zhu L. Quercetin assists fluconazole to inhibit biofilm formations of fluconazole-resistant Candida albicans in in vitro and in vivo antifungal managements of vulvovaginal candidiasis. Cell Physiol Biochem. 2016;40(3\u20134):727\u201342.","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"12653_CR84","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1128\/AAC.00479-10","volume":"54","author":"J Garnacho-Montero","year":"2010","unstructured":"Garnacho-Montero J, D\u00edaz-Mart\u00edn A, Garc\u00eda-Cabrera E, Ruiz P\u00e9rez de Pipa\u00f3n M, Hern\u00e1ndez-Caballero C, Aznar-Mart\u00edn J, et al. Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother. 2010;54(8):3149\u201354.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"12653_CR85","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/jac\/dkac075","volume":"77","author":"P-C Georgiou","year":"2022","unstructured":"Georgiou P-C, Arendrup MC, Meletiadis J. Early phenotypic detection of fluconazole-and anidulafungin-resistant Candida glabrata isolates. J Antimicrob Chemother. 2022;77(6):1655\u201361.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"12653_CR86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.51429\/EJMM29305","volume":"29","author":"MM Ghonaim","year":"2020","unstructured":"Ghonaim MM, Labeeb AZ, Eliwa AI, Salem EH. Molecular diagnosis and antifungal resistance and biofilm production profiles among Candida species isolated from immunocompromised patients at menoufia university hospitals. Egypt J Med Microbiol. 2020;29(3):37\u201345.","journal-title":"Egypt J Med Microbiol"},{"issue":"2","key":"12653_CR87","doi-asserted-by":"publisher","first-page":"217","DOI":"10.33073\/pjm-2014-028","volume":"63","author":"M Go\u0142a\u015b","year":"2014","unstructured":"Go\u0142a\u015b M, Netsvyetayeva I, Sikora M, Piskorska K, Sulik-Tyszka B, Swoboda-Kope\u0107 E. Trends in antifungal susceptibility of Candida species\u2013one year observation. Pol J Microbiol. 2014;63(2):217.","journal-title":"Pol J Microbiol"},{"issue":"12","key":"12653_CR88","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/jac\/dkt283","volume":"68","author":"GM Gonz\u00e1lez","year":"2013","unstructured":"Gonz\u00e1lez GM, Trevi\u00f1o-Rangel RdJ, Palma-Nicol\u00e1s JP, Mart\u00ednez C, Gonz\u00e1lez JG, Ayala J, et al. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in mexico: a nationwide surveillance study. J Antimicrob Chemother. 2013;68(12):2847\u201351.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"12653_CR89","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/jac\/dkr511","volume":"67","author":"SA Grim","year":"2012","unstructured":"Grim SA, Berger K, Teng C, Gupta S, Layden JE, Janda WM, et al. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother. 2012;67(3):707\u201314.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"12653_CR90","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.cmi.2024.07.002","volume":"30","author":"J Guinea","year":"2024","unstructured":"Guinea J, Alcoceba E, Padilla E, Ram\u00edrez A, De Carolis E, Sanguinetti M, et al. Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme. Clin Microbiol Infect. 2024;30(11):1447\u201352.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"12653_CR91","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1128\/AAC.02155-13","volume":"58","author":"J Guinea","year":"2014","unstructured":"Guinea J, Zaragoza \u00d3, Escribano P, Mart\u00edn-Mazuelos E, Pem\u00e1n J, S\u00e1nchez-Reus F, et al. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother. 2014;58(3):1529\u201337.","journal-title":"Antimicrob Agents Chemother"},{"key":"12653_CR92","doi-asserted-by":"crossref","unstructured":"G\u00fczel AB, Ayd\u0131n M, Meral M, Kalkanc\u0131 A, Ilkit M. Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates. Infectious diseases in obstetrics and gynecology. 2013;2013.","DOI":"10.1155\/2013\/698736"},{"issue":"1","key":"12653_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.diagmicrobio.2004.12.006","volume":"52","author":"KC Hazen","year":"2005","unstructured":"Hazen KC, Stei J, Darracott C, Breathnach A, May J, Howell SA. Isolation of cholesterol-dependent Candida glabrata from clinical specimens. Diagn Microbiol Infect Dis. 2005;52(1):35\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"12653_CR94","doi-asserted-by":"publisher","first-page":"e0293390","DOI":"10.1371\/journal.pone.0293390","volume":"18","author":"Z-e Huma","year":"2023","unstructured":"Huma Z-e-, Saleem S, Imran M, Jabeen K, Arshad F, Amar A. Screening of C. auris among Candida isolates from various tertiary care institutions in Lahore by VITEK 2 and real time PCR based molecular technique. PLoS ONE. 2023;18(10):e0293390.","journal-title":"PLoS ONE"},{"issue":"8","key":"12653_CR95","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00284-022-02915-4","volume":"79","author":"M Kahraman","year":"2022","unstructured":"Kahraman M, Karahan AG, Terzio\u011flu ME. Characterization of some microorganisms from human stool samples and determination of their effects on CT26 colorectal carcinoma cell line. Curr Microbiol. 2022;79(8):225.","journal-title":"Curr Microbiol"},{"issue":"5","key":"12653_CR96","first-page":"821","volume":"12","author":"B Kaskatepe","year":"2013","unstructured":"Kaskatepe B, Yildiz S. Investigation of association between slime production by Candida spp and susceptibility to fluconazole and voriconazole. Trop J Pharm Res. 2013;12(5):821\u20135.","journal-title":"Trop J Pharm Res"},{"issue":"1","key":"12653_CR97","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3314\/mmj.55.E1","volume":"55","author":"S Katsuragi","year":"2014","unstructured":"Katsuragi S, Sata M, Kobayashi Y, Miyoshi T, Yamashita Y, Neki R, et al. Antifungal susceptibility of Candida isolates at one institution. Med Mycol J. 2014;55(1):E1\u20137.","journal-title":"Med Mycol J"},{"issue":"5","key":"12653_CR98","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1128\/AAC.48.5.1600-1613.2004","volume":"48","author":"R Kaur","year":"2004","unstructured":"Kaur R, Casta\u00f1o I, Cormack BP. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob Agents Chemother. 2004;48(5):1600\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"12653_CR99","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3201\/eid2910.230181","volume":"29","author":"D Kekana","year":"2023","unstructured":"Kekana D, Naicker SD, Shuping L, Velaphi S, Nakwa FL, Wadula J, et al. Candida auris clinical isolates associated with outbreak in neonatal unit of tertiary academic hospital, South Africa. Emerg Infect Dis. 2023;29(10):2044.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"12653_CR100","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/jof9050539","volume":"9","author":"JH Kim","year":"2023","unstructured":"Kim JH, Suh JW, Kim MJ. Evaluation of fluconazole versus echinocandins for treatment of candidemia caused by susceptible common Candida species: A propensity score matching analysis. J Fungi. 2023;9(5):539.","journal-title":"J Fungi"},{"issue":"5","key":"12653_CR101","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1099\/jmm.0.001189","volume":"69","author":"M Kord","year":"2020","unstructured":"Kord M, Salehi M, Khodavaisy S, Hashemi SJ, Daie Ghazvini R, Rezaei S, et al. Epidemiology of yeast species causing bloodstream infection in Tehran, Iran (2015\u20132017); superiority of 21-plex PCR over the Vitek 2 system for yeast identification. J Med Microbiol. 2020;69(5):712\u201320.","journal-title":"J Med Microbiol"},{"issue":"1","key":"12653_CR102","doi-asserted-by":"publisher","first-page":"e70026","DOI":"10.1111\/myc.70026","volume":"68","author":"V Kroustali","year":"2025","unstructured":"Kroustali V, Resoulai E, Kanioura L, Siopi M, Meletiadis J, Antonopoulou S. Epidemiology of vulvovaginal candidiasis in greece: A 2-Year Single\u2010Centre study. Mycoses. 2025;68(1):e70026.","journal-title":"Mycoses"},{"issue":"1","key":"12653_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-253","volume":"13","author":"F-q Li","year":"2013","unstructured":"Li F-q, Ma C-f, Shi L-n, Lu J-f, Wang Y, Huang M, et al. Diagnostic value of Immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia. BMC Infect Dis. 2013;13(1):1\u20139.","journal-title":"BMC Infect Dis"},{"key":"12653_CR104","doi-asserted-by":"publisher","first-page":"103243","DOI":"10.1016\/j.fgb.2019.103243","volume":"131","author":"SR Lockhart","year":"2019","unstructured":"Lockhart SR. Candida auris and multidrug resistance: defining the new normal. Fungal Genet Biol. 2019;131:103243.","journal-title":"Fungal Genet Biol"},{"issue":"2","key":"12653_CR105","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3109\/13693786.2011.592153","volume":"50","author":"TJ Lott","year":"2012","unstructured":"Lott TJ, Frade JP, Lyon GM, Iqbal N, Lockhart SR. Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities. Sabouraudia. 2012;50(2):136\u201342.","journal-title":"Sabouraudia"},{"key":"12653_CR106","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1590\/S0100-879X2010007500125","volume":"43","author":"C Loureiro y Penha","year":"2010","unstructured":"Loureiro y Penha C, Kubitschek P, Larcher G, Perales J, Rodriguez Le\u00f3n I, Lopes-Bezerra L, et al. Proteomic analysis of cytosolic proteins associated with Petite mutations in Candida glabrata. Braz J Med Biol Res. 2010;43:1203\u201314.","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"12653_CR107","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1128\/JCM.02363-09","volume":"48","author":"GM Lyon","year":"2010","unstructured":"Lyon GM, Karatela S, Sunay S, Adiri Y. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol. 2010;48(4):1270\u20135.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"12653_CR108","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1139\/w05-148","volume":"52","author":"JP Lyon","year":"2006","unstructured":"Lyon JP, da Costa SC, Totti VMG, Munhoz MFV, de Resende MA. Predisposing conditions for Candida spp. Carriage in the oral cavity of denture wearers and individuals with natural teeth. Can J Microbiol. 2006;52(5):462\u20137.","journal-title":"Can J Microbiol"},{"issue":"1","key":"12653_CR109","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1128\/JCM.02366-12","volume":"51","author":"MMC Magri","year":"2013","unstructured":"Magri MMC, Gomes-Gouv\u00eaa MS, de Freitas VLT, Motta AL, Moretti ML, Shikanai-Yasuda MA. Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil. J Clin Microbiol. 2013;51(1):268\u201377.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"12653_CR110","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1128\/AAC.00998-08","volume":"53","author":"N Mandras","year":"2009","unstructured":"Mandras N, Tullio V, Allizond V, Scalas D, Banche G, Roana J, et al. In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. Determined by disk diffusion testing in Turin, Italy. Antimicrob Agents Chemother. 2009;53(4):1657\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"12653_CR111","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1128\/AAC.02670-14","volume":"58","author":"LJ Marcos-Zambrano","year":"2014","unstructured":"Marcos-Zambrano LJ, Escribano P, S\u00e1nchez C, Mu\u00f1oz P, Bouza E, Guinea J. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center. Antimicrob Agents Chemother. 2014;58(8):4565\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"12653_CR112","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.indcrop.2015.05.067","volume":"74","author":"N Martins","year":"2015","unstructured":"Martins N, Barros L, Henriques M, Silva S, Ferreira IC. Activity of phenolic compounds from plant origin against Candida species. Ind Crops Prod. 2015;74:648\u201370.","journal-title":"Ind Crops Prod"},{"issue":"7","key":"12653_CR113","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1017\/ice.2022.204","volume":"44","author":"AS Maurice","year":"2023","unstructured":"Maurice AS, Parti U, Anikst VE, Harper T, Mirasol R, Dayo AJ, et al. Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in Southern California, 2019\u20132022. Infect Control Hosp Epidemiol. 2023;44(7):1093\u2013101.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"12653_CR114","doi-asserted-by":"publisher","unstructured":"Mayr E-M, Ram\u00edrez-Zavala B, Kr\u00fcger I, Morschh\u00e4user J. A zinc cluster transcription factor contributes to the intrinsic fluconazole resistance of Candida auris. Msphere. 2020;5(2). https:\/\/doi.org\/10.1128\/msphere. 00279\u2009\u2013\u200920.","DOI":"10.1128\/msphere"},{"issue":"1","key":"12653_CR115","doi-asserted-by":"publisher","first-page":"e01161","DOI":"10.1128\/jcm.01161-23","volume":"62","author":"LR McTaggart","year":"2024","unstructured":"McTaggart LR, Eshaghi A, Hota S, Poutanen SM, Johnstone J, De Luca DG, et al. First Canadian report of transmission of fluconazole-resistant Candida parapsilosis within two hospital networks confirmed by genomic analysis. J Clin Microbiol. 2024;62(1):e01161\u201323.","journal-title":"J Clin Microbiol"},{"issue":"45","key":"12653_CR116","doi-asserted-by":"publisher","first-page":"2400128","DOI":"10.2807\/1560-7917.ES.2024.29.45.2400128","volume":"29","author":"J Meletiadis","year":"2024","unstructured":"Meletiadis J, Siopi M, Spruijtenburg B, Georgiou P-C, Kostoula M, Vourli S, et al. Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023. Eurosurveillance. 2024;29(45):2400128.","journal-title":"Eurosurveillance"},{"key":"12653_CR117","doi-asserted-by":"crossref","unstructured":"Menezes EA, Mendes LG, Cunha FA. Antifungal resistance of Candida tropicalis isolated in the state of Cear\u00e1. Rev Soc Bras Med Trop. 2009;42(3).","DOI":"10.1590\/S0037-86822009000300024"},{"issue":"2","key":"12653_CR118","doi-asserted-by":"publisher","first-page":"e00577","DOI":"10.1128\/msphere.00577-23","volume":"9","author":"E Misas","year":"2024","unstructured":"Misas E, Escand\u00f3n PL, Gade L, Caceres DH, Hurst S, Le N, et al. Genomic epidemiology and antifungal-resistant characterization of Candida auris, Colombia, 2016\u20132021. Msphere. 2024;9(2):e00577\u201323.","journal-title":"Msphere"},{"issue":"2","key":"12653_CR119","doi-asserted-by":"publisher","first-page":"e01140","DOI":"10.1128\/jcm.01140-23","volume":"62","author":"E Misas","year":"2024","unstructured":"Misas E, Seagle E, Jenkins E, Rajeev M, Hurst S, Nunnally N, et al. Genomic description of acquired fluconazole-and echinocandin-resistance in patients with serial Candida glabrata isolates. J Clin Microbiol. 2024;62(2):e01140\u201323.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"12653_CR120","first-page":"1816","volume":"47","author":"M Mobin","year":"2018","unstructured":"Mobin M, Szeszs MW, Takahashi JP, Martins M, de HIPP\u00d3LITO DDC, Porto JCS, et al. Antifungal susceptibility of Candida species isolated from horticulturists with onychomycosis in Piau\u00ed, Brazil. Iran J Public Health. 2018;47(12):1816.","journal-title":"Iran J Public Health"},{"issue":"9","key":"12653_CR121","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1128\/AAC.46.9.2829-2841.2002","volume":"46","author":"G Moran","year":"2002","unstructured":"Moran G, Sullivan D, Morschh\u00e4user J, Coleman D. The Candida Dubliniensis CdCDR1 gene is not essential for fluconazole resistance. Antimicrob Agents Chemother. 2002;46(9):2829\u201341.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"12653_CR122","doi-asserted-by":"publisher","first-page":"e13776","DOI":"10.1111\/myc.13776","volume":"67","author":"JV Mulet-Bayona","year":"2024","unstructured":"Mulet-Bayona JV, Cancino\u2010Mu\u00f1oz I, Salvador\u2010Garc\u00eda C, Tormo\u2010Palop N, Guna\u2010Serrano MR, Ferrer\u2010G\u00f3mez C, et al. Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years. Mycoses. 2024;67(8):e13776.","journal-title":"Mycoses"},{"issue":"1","key":"12653_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-82","volume":"13","author":"A Mulu","year":"2013","unstructured":"Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, et al. Frequent detection of \u2018azole\u2019resistant Candida species among late presenting AIDS patients in Northwest Ethiopia. BMC Infect Dis. 2013;13(1):1\u201310.","journal-title":"BMC Infect Dis"},{"key":"12653_CR124","unstructured":"Nasira Shaikh NS, Vilas Jahagirdar VJ, Sarita Kothadia SK. Basavraj Nagoba BN. Antifungal drug resistance in Candida species. 2013."},{"issue":"3","key":"12653_CR125","first-page":"417","volume":"45","author":"SD Navarathinam","year":"2023","unstructured":"Navarathinam SD, Neoh H-m, Tan TL, Wahab AA, Tzar MN, Ding CH. Antifungal susceptibility profile and biofilm-producing capability of Candida tropicalis isolates in a tertiary medical centre. Malays J Pathol. 2023;45(3):417\u201324.","journal-title":"Malays J Pathol"},{"issue":"2","key":"12653_CR126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/mmy\/myw063","volume":"55","author":"S Neji","year":"2017","unstructured":"Neji S, Trabelsi H, Hadrich I, Cheikhrouhou F, Sellami H, Makni F, et al. Molecular study of the Candida parapsilosis complex in Sfax, Tunisia. Med Mycol. 2017;55(2):137\u201344.","journal-title":"Med Mycol"},{"key":"12653_CR127","doi-asserted-by":"crossref","unstructured":"Neves-Junior A, Cart\u00e1genes-Pinto AC, Rocha DA, S\u00e1 LF, Junqueira ML, Ferreira-Pereira A. Prevalence and fluconazole susceptibility profile of Candida spp. Clinical isolates in a Brazilian tertiary hospital in Minas Gerais, Brazil. Anais da Academia Brasileira de Ci\u00eancias. 2015;87:1349\u201359.","DOI":"10.1590\/0001-3765201520140717"},{"issue":"4","key":"12653_CR128","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/medicina59040743","volume":"59","author":"F Nikoomanesh","year":"2023","unstructured":"Nikoomanesh F, Falahatinejad M, \u010cern\u00e1kov\u00e1 L, Dos Santos ALS, Mohammadi SR, Rafiee M, et al. Combination of Farnesol with common antifungal drugs: inhibitory effect against Candida species isolated from women with RVVC. Medicina. 2023;59(4):743.","journal-title":"Medicina"},{"issue":"6","key":"12653_CR129","first-page":"997","volume":"136","author":"JK Oberoi","year":"2012","unstructured":"Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at new Delhi, India. Indian J Med Res. 2012;136(6):997.","journal-title":"Indian J Med Res"},{"issue":"10","key":"12653_CR130","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1128\/AAC.03035-14","volume":"58","author":"G Pankey","year":"2014","unstructured":"Pankey G, Ashcraft D, Kahn H, Ismail A. Time-kill assay and etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata. Antimicrob Agents Chemother. 2014;58(10):5795\u2013800.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"12653_CR131","first-page":"1","volume":"5","author":"S Paul","year":"2019","unstructured":"Paul S, Kannan I, Mohanram K. Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients. Curr Med Mycol. 2019;5(3):1.","journal-title":"Curr Med Mycol"},{"issue":"11","key":"12653_CR132","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1128\/JCM.00403-07","volume":"45","author":"M Pfaller","year":"2007","unstructured":"Pfaller M, Diekema D, Procop G, Rinaldi M. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol. 2007;45(11):3522\u20138.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"12653_CR133","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1128\/JCM.00946-09","volume":"47","author":"M Pfaller","year":"2009","unstructured":"Pfaller M, Messer S, Hollis R, Boyken L, Tendolkar S, Kroeger J, et al. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the united States in 2001 to 2007. J Clin Microbiol. 2009;47(10):3185\u201390.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"12653_CR134","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.diagmicrobio.2010.01.002","volume":"67","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, et al. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK global antifungal surveillance program. Diagn Microbiol Infect Dis. 2010;67(2):162\u201371.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"12653_CR135","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.diagmicrobio.2013.05.019","volume":"77","author":"MA Pfaller","year":"2013","unstructured":"Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diagn Microbiol Infect Dis. 2013;77(1):37\u201340.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"12653_CR136","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/mmy\/myx058","volume":"56","author":"S Pharkjaksu","year":"2018","unstructured":"Pharkjaksu S, Chongtrakool P, Suwannakarn K, Ngamskulrungroj P. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015. Med Mycol. 2018;56(4):426\u201333.","journal-title":"Med Mycol"},{"issue":"6","key":"12653_CR137","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1128\/JCM.02070-08","volume":"47","author":"B Posteraro","year":"2009","unstructured":"Posteraro B, Martucci R, La Sorda M, Fiori B, Sanglard D, De Carolis E, et al. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. J Clin Microbiol. 2009;47(6):1927\u201330.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"12653_CR138","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/jac\/dkf049","volume":"49","author":"G Ramage","year":"2002","unstructured":"Ramage G, Bachmann S, Patterson TF, Wickes BL, L\u00f3pez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother. 2002;49(6):973\u201380.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"12653_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.39.1.1","volume":"39","author":"JH Rex","year":"1995","unstructured":"Rex JH, Rinaldi M, Pfaller M. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother. 1995;39(1):1\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"12653_CR140","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/myc.12457","volume":"59","author":"MFG Rocha","year":"2016","unstructured":"Rocha MFG, Alencar LPd, Paiva M, Melo LM, Bandeira SP, Ponte Y, et al. Cross-resistance to fluconazole induced by exposure to the agricultural Azole tetraconazole: an environmental resistance school? Mycoses. 2016;59(5):281\u201390.","journal-title":"Mycoses"},{"issue":"4","key":"12653_CR141","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/2047-783X-16-4-187","volume":"16","author":"A Rodloff","year":"2011","unstructured":"Rodloff A, Koch D, Schaumann R. Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res. 2011;16(4):187\u201395.","journal-title":"Eur J Med Res"},{"issue":"2","key":"12653_CR142","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/jac\/dkl221","volume":"58","author":"PD Rogers","year":"2006","unstructured":"Rogers PD, Vermitsky J-P, Edlind TD, Hilliard GM. Proteomic analysis of experimentally induced Azole resistance in Candida glabrata. J Antimicrob Chemother. 2006;58(2):434\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"12653_CR143","doi-asserted-by":"crossref","unstructured":"Sachin Deorukhkar SD, Santosh Saini SS. Virulence markers and antifungal susceptibility profile of Candida glabrata: an emerging pathogen. 2014.","DOI":"10.1155\/2014\/456878"},{"issue":"2","key":"12653_CR144","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","volume":"49","author":"M Sanguinetti","year":"2005","unstructured":"Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of Azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother. 2005;49(2):668\u201379.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"12653_CR145","first-page":"215","volume":"6","author":"A Sharifzadeh","year":"2016","unstructured":"Sharifzadeh A, Shokri H. Antifungal activity of essential oils from Iranian plants against fluconazole-resistant and fluconazole-susceptible Candida albicans. Avicenna J Phytomedicine. 2016;6(2):215.","journal-title":"Avicenna J Phytomedicine"},{"issue":"4","key":"12653_CR146","first-page":"389","volume":"24","author":"SS Sharifzadeh","year":"2023","unstructured":"Sharifzadeh SS, Lotfali E, Lesan S, Farrokhnia T. Antifungal effect of probiotic Lactobacillus casei on Drug-Resistant oral Candida albicans isolated from patients with hematological malignancy: an in vitro study. J Dent. 2023;24(4):389.","journal-title":"J Dent"},{"issue":"8","key":"12653_CR147","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1128\/JCM.02379-08","volume":"47","author":"AP Silva","year":"2009","unstructured":"Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J Clin Microbiol. 2009;47(8):2392\u20137.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"12653_CR148","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jac\/dku511","volume":"70","author":"A Silva-Dias","year":"2015","unstructured":"Silva-Dias A, Miranda IM, Branco J, Cobrado L, Monteiro-Soares M, Pina-Vaz C, et al. In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida species. J Antimicrob Chemother. 2015;70(4):1083\u201393.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"12653_CR149","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1128\/JCM.39.3.949-953.2001","volume":"39","author":"G St-Germain","year":"2001","unstructured":"St-Germain G, Laverdiere M, Pelletier R, Bourgault A-M, Libman M, Lemieux C, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol. 2001;39(3):949\u201353.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"12653_CR150","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4248\/IJOS.09020","volume":"1","author":"J Sun","year":"2009","unstructured":"Sun J, Qi C, Lafleur MD, Qi Q. Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China. Int J Oral Sci. 2009;1(3):156\u201362.","journal-title":"Int J Oral Sci"},{"key":"12653_CR151","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1017\/S0950268823001346","volume":"151","author":"J Szekely","year":"2023","unstructured":"Szekely J, Rakchang W, Rattanaphan P, Kositpantawong N. Fluconazole and Echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak. Epidemiol Infect. 2023;151:e146.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"12653_CR152","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jhin.2004.01.017","volume":"57","author":"A Tortorano","year":"2004","unstructured":"Tortorano A, Caspani L, Rigoni A, Biraghi E, Sicignano A, Viviani M. Candidosis in the intensive care unit: a 20-year survey. J Hosp Infect. 2004;57(1):8\u201313.","journal-title":"J Hosp Infect"},{"issue":"5","key":"12653_CR153","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/13693786.2012.745953","volume":"51","author":"I Tosun","year":"2013","unstructured":"Tosun I, Akyuz Z, Guler NC, Gulmez D, Bayramoglu G, Kaklikkaya N, et al. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples. Med Mycol. 2013;51(5):483\u201392.","journal-title":"Med Mycol"},{"issue":"2","key":"12653_CR154","first-page":"8","volume":"8","author":"N Vaseghi","year":"2022","unstructured":"Vaseghi N, Piramoon M, Khojasteh S, Abbasi K, Mohseni S, Javidnia J, et al. Post-antifungal effect of the combination of Anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and-resistant Candida albicans. Curr Med Mycol. 2022;8(2):8.","journal-title":"Curr Med Mycol"},{"issue":"5","key":"12653_CR155","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1099\/jmm.0.46664-0","volume":"56","author":"J-S Wang","year":"2007","unstructured":"Wang J-S, Li S-Y, Yang Y-L, Chou H-H, Lo H-J. Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan. J Med Microbiol. 2007;56(5):650\u20133.","journal-title":"J Med Microbiol"},{"issue":"4","key":"12653_CR156","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/jac\/dkn015","volume":"61","author":"Y Xu","year":"2008","unstructured":"Xu Y, Chen L, Li C. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. J Antimicrob Chemother. 2008;61(4):798\u2013804.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"12653_CR157","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/13693780903154070","volume":"48","author":"Y Yang","year":"2010","unstructured":"Yang Y, Cheng M, Wang C, Wang A, Cheng W, Lo H. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med Mycol. 2010;48(2):328\u201334.","journal-title":"Med Mycol"},{"key":"12653_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-5751-7-12","volume":"7","author":"Y-L Yang","year":"2008","unstructured":"Yang Y-L, Cheng M-F, Chang Y-W, Young T-G, Chi H, Lee SC, et al. Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. J Negat Results Biomed. 2008;7:1\u20135.","journal-title":"J Negat Results Biomed"},{"key":"12653_CR159","doi-asserted-by":"crossref","unstructured":"Yang Y-L, Li S-Y, Cheng H-H, Lo H-J, tw, THhno. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. BMC infectious diseases. 2005;5:1\u20135.","DOI":"10.1186\/1471-2334-5-99"},{"issue":"11","key":"12653_CR160","first-page":"2459","volume":"7","author":"R Yashavanth","year":"2013","unstructured":"Yashavanth R, Shiju M, Bhaskar U, Ronald R, Anita K. Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of Mangalore. J Clin Diagn Research: JCDR. 2013;7(11):2459.","journal-title":"J Clin Diagn Research: JCDR"},{"issue":"2","key":"12653_CR161","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrp.2012.04.001","volume":"3","author":"JI Yoo","year":"2012","unstructured":"Yoo JI, Choi CW, Kim HS, Yoo JS, Jeong YH, Lee YS. Proteomic analysis of cellular and membrane proteins in fluconazole-resistant Candida glabrata. Osong Public Health Res Perspect. 2012;3(2):74\u20138.","journal-title":"Osong Public Health Res Perspect"},{"issue":"1","key":"12653_CR162","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.phrp.2010.12.009","volume":"1","author":"JI Yoo","year":"2010","unstructured":"Yoo JI, Choi CW, Lee KM, Lee YS. Gene expression and identification related to fluconazole resistance of Candida glabrata strains. Osong Public Health Res Perspect. 2010;1(1):36\u201341.","journal-title":"Osong Public Health Res Perspect"},{"issue":"4","key":"12653_CR163","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0974-777X.91059","volume":"3","author":"K Zomorodian","year":"2011","unstructured":"Zomorodian K, Rahimi MJ, Pakshir K, Motamedi M, Ghiasi MR, Rezashah H. Determination of antifungal susceptibility patterns among the clinical isolates of Candida species. J Global Infect Dis. 2011;3(4):357.","journal-title":"J Global Infect Dis"},{"key":"12653_CR164","doi-asserted-by":"crossref","unstructured":"Tu J, Sheng C. Triazole antifungal drug\u2014fluconazole. Medicinal chemistry and drug development. Elsevier; 2025. pp. 449\u201364.","DOI":"10.1016\/B978-0-443-27402-2.00017-6"},{"issue":"2","key":"12653_CR165","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/jof11020087","volume":"11","author":"AH Abu-Humaidan","year":"2025","unstructured":"Abu-Humaidan AH, Alshdaifat A, Awajan D, Abu-Hmidan M, Alshdifat A, Hasan H, et al. The antimicrobial resistance of candida: A 5-Year retrospective analysis at a tertiary hospital in Jordan. J Fungi. 2025;11(2):87.","journal-title":"J Fungi"},{"key":"12653_CR166","doi-asserted-by":"crossref","unstructured":"Topa\u00e7 T, A\u011fca H, Sa\u011flam S, Efe K, Ener BJMB. Comparison of clinical laboratory standards Institute (CLSI) and European committee on antimicrobial susceptibility testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates. 2018;52(1):35\u201348.","DOI":"10.5578\/mb.63991"},{"issue":"1","key":"12653_CR167","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/JCM.01096-09","volume":"48","author":"N Bourgeois","year":"2010","unstructured":"Bourgeois N, Dehandschoewercker L, Bertout S, Bousquet P-J, Rispail P, Lachaud L. Antifungal susceptibility of 205 Candida spp. Isolated primarily during invasive candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and etest methods. J Clin Microbiol. 2010;48(1):154\u201361.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"12653_CR168","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1128\/JCM.00925-15","volume":"53","author":"F Lamoth","year":"2015","unstructured":"Lamoth F, Alexander BD. Comparing etest and broth microdilution for antifungal susceptibility testing of the most-relevant pathogenic molds. J Clin Microbiol. 2015;53(10):3176\u201381.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"12653_CR169","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11046-011-9413-y","volume":"172","author":"DY Metin","year":"2011","unstructured":"Metin DY, Hilmioglu-Polat S, Samlioglu P, Doganay-Oflazoglu B, Inci R, Tumbay E. Evaluation of antifungal susceptibility testing with microdilution and etest methods of Candida blood isolates. Mycopathologia. 2011;172(3):187\u201399.","journal-title":"Mycopathologia"},{"issue":"6","key":"12653_CR170","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1128\/JCM.02087-06","volume":"45","author":"DJ Diekema","year":"2007","unstructured":"Diekema DJ, Messer SA, Hollis RJ, Boyken LB, Tendolkar S, Kroeger J, et al. Evaluation of etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. Against posaconazole. J Clin Microbiol. 2007;45(6):1974\u20137.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"12653_CR171","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/JCM.00937-12","volume":"50","author":"M Pfaller","year":"2012","unstructured":"Pfaller M, Diekema D. Progress in antifungal susceptibility testing of Candida spp. By use of clinical and laboratory standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol. 2012;50(9):2846\u201356.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"12653_CR172","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1128\/JCM.02591-05","volume":"44","author":"CR Sims","year":"2006","unstructured":"Sims CR, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J Clin Microbiol. 2006;44(6):2105\u20138.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"12653_CR173","doi-asserted-by":"publisher","first-page":"103582","DOI":"10.1016\/j.sjbs.2023.103582","volume":"30","author":"MA Salam","year":"2023","unstructured":"Salam MA, Al-Amin MY, Pawar JS, Akhter N, Lucy IB. Conventional methods and future trends in antimicrobial susceptibility testing. Saudi J Biol Sci. 2023;30(3):103582.","journal-title":"Saudi J Biol Sci"},{"issue":"10","key":"12653_CR174","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/jof10100685","volume":"10","author":"K Odoj","year":"2024","unstructured":"Odoj K, Garlasco J, Pezzani MD, Magnabosco C, Ortiz D, Manco F, et al. Tracking candidemia trends and antifungal resistance patterns across europe: an In-Depth analysis of surveillance systems and surveillance studies. J Fungi. 2024;10(10):685.","journal-title":"J Fungi"},{"key":"12653_CR175","doi-asserted-by":"crossref","unstructured":"Arendrup MC, Patterson, TFJTJoid. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. 2017;216(suppl_3):S445-S51.","DOI":"10.1093\/infdis\/jix131"},{"key":"12653_CR176","doi-asserted-by":"crossref","unstructured":"Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, et al. Molecular mechanisms associated with fluconazole resistance in clinical Candida albicans isolates from India. 2016;59(2):93\u2013100.","DOI":"10.1111\/myc.12439"},{"key":"12653_CR177","doi-asserted-by":"crossref","unstructured":"Morschh\u00e4user JJJom. The development of fluconazole resistance in Candida albicans\u2013an example of microevolution of a fungal pathogen. 2016;54(3):192\u2013201.","DOI":"10.1007\/s12275-016-5628-4"},{"key":"12653_CR178","first-page":"2173","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS. Rogers PDJFim. Azole antifungal resistance in Candida albicans and emerging non-albicans. Candida Species. 2017;7:2173.","journal-title":"Candida Species"},{"key":"12653_CR179","doi-asserted-by":"crossref","unstructured":"Garnacho-Montero J, D\u00edaz-Mart\u00edn A, Garc\u00eda-Cabrera E, Ruiz P\u00e9rez de Pipa\u00f3n M, Hern\u00e1ndez-Caballero C, Aznar-Mart\u00edn J, et al. Risk factors for fluconazole-resistant candidemia. 2010;54(8):3149\u201354.","DOI":"10.1128\/AAC.00479-10"},{"key":"12653_CR180","doi-asserted-by":"crossref","unstructured":"Maenza JR, Keruly JC, Moore RD, Chaisson RE, Merz WG. Gallant JEJTJoid. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. 1996;173(1):219\u2009\u2013\u200925.","DOI":"10.1093\/infdis\/173.1.219"},{"issue":"1","key":"12653_CR181","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mycmed.2017.12.008","volume":"28","author":"G Sadeghi","year":"2018","unstructured":"Sadeghi G, Ebrahimi-Rad M, Mousavi S, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile. J De Mycol Medicale. 2018;28(1):51\u20138.","journal-title":"J De Mycol Medicale"},{"key":"12653_CR182","doi-asserted-by":"crossref","unstructured":"Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017:237\u201345.","DOI":"10.2147\/IDR.S118892"},{"issue":"3","key":"12653_CR183","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/jac\/dku460","volume":"70","author":"M Xiao","year":"2015","unstructured":"Xiao M, Fan X, Chen SC-A, Wang H, Sun Z-Y, Liao K, et al. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in china: 3 year National surveillance. J Antimicrob Chemother. 2015;70(3):802\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"12653_CR184","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","volume":"87","author":"MC Arendrup","year":"2023","unstructured":"Arendrup MC, Arikan-Akdagli S, J\u00f8rgensen KM, Barac A, Steinmann J, Toscano C, et al. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study. J Infect. 2023;87(5):428\u201337.","journal-title":"J Infect"},{"issue":"1","key":"12653_CR185","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bjid.2017.10.005","volume":"22","author":"LB Denardi","year":"2018","unstructured":"Denardi LB, Dalla-Lana BH, de Jesus FPK, Severo CB, Santurio JM, Zanette RA, et al. In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil. Brazilian J Infect Dis. 2018;22(1):30\u20136.","journal-title":"Brazilian J Infect Dis"},{"key":"12653_CR186","doi-asserted-by":"crossref","unstructured":"Akinbobola AB, Shilla DJ, Shilla DA, Quilliam RS. Fluconazole resistant pathogenic yeasts isolated from plastic debris on recreational public beaches in West and East Africa. Biologia. 2025:1\u20137.","DOI":"10.1007\/s11756-025-01981-w"},{"issue":"1","key":"12653_CR187","doi-asserted-by":"publisher","first-page":"106846","DOI":"10.1016\/j.ijantimicag.2023.106846","volume":"62","author":"SS Kanj","year":"2023","unstructured":"Kanj SS, Haddad SF, Meis JF, Verweij PE, Voss A, Rautemaa-Richardson R, et al. The battle against fungi: lessons in antifungal stewardship from COVID 19 times. Int J Antimicrob Agents. 2023;62(1):106846.","journal-title":"Int J Antimicrob Agents"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12653-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:10:08Z","timestamp":1771600208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12653-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":187,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12653"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12653-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received ethical approval from the Health Research Ethics Committee of Golestan University of Medical Sciences (Code: IR.GOUMS.REC.1401.095). The research was carried out in full adherence to the ethical guidelines outlined in the Declaration of Helsinki. All participants provided informed consent before taking part in the study, with their privacy protected and the right to withdraw at any time respected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}